Recent News

By Category: Biosafety

NSABB and H5N1 redactions: Biosecurity runs up against scientific endeavor

(American Society for Microbiology) In response to recent actions of the US National Science Advisory Board for Biosecurity, which recommended that two scientific journals withhold crucial details in upcoming reports about experiments with a novel strain of the bird flu virus, H5N1, the American Society for Microbiology will publish a special series of commentaries by Read More »

February 1, 2012
| Filed under Europe, North America, Biosafety, Public Health, and Research
Share

Kansas residents oppose plans for federal lab

(San Francisco Examiner) The $650 million lab would do research on deadly plant and animal pathogens, including foot-and-mouth disease, and critics said during the two-hour meeting that the risks outweighed the benefits of building it near Kansas State University.

January 30, 2012
| Filed under North America, Agriculture, Biosafety, Policy & Initiatives, and Research
Share

Sunday Dialogue: Bird Flu Experiments

(New York Times) Further, all stocks of these mutants, as well as their “recipes” should be deposited immediately in highest-security Biosafety Level 4 facilities, and all further research conducted only in such facilities, thereby maximizing environmental safety and …

January 30, 2012
| Filed under Europe, North America, Biosafety, Policy & Initiatives, and Research
Share

Flu research and public safety

(The Economist) The American government, in the shape of the country’s National Scientific Advisory Board for Biosecurity (NSABB), called on the world’s two leading scientific journals to censor research. Nature and Science were about to publish studies by researchers …

January 30, 2012
| Filed under North America, Biosafety, Policy & Initiatives, and Research
Share

Bio-security, an emerging challenge

(Hindu Business Line) Action is needed at the national and international levels to deal with this threat. Biotech research is conducted in a wide range of institutions, in government laboratories, universities, and by the private sector. Freedom to do research in biotechnology shouldn’t be hampered, and intellectual property rights must be protected. However, the risks Read More »